PA32540 (Enteric-Coated Aspirin 325 mg + Immediate-Release Omeprazole 40 mg) Is Associated with Significantly Fewer Gastric Ulcers and Significantly Less Endoscopic Erosive Esophagitis than Enteric-Coated Aspirin (EC-ASA) Alone: Results of Two Phase 3 studies ACG Auxiliary Award (Member/Fellow) Presidential Poster | Publicación